Literature DB >> 19428960

Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information.

F Eusebi1, E Palma, M Amici, R Miledi.   

Abstract

Despite huge improvements in neurobiological approaches for investigating the functional properties of neurotransmitter receptors and ion channels, many difficulties are still encountered when focusing on the human brain. Electrophysiological studies aimed at performing direct determinations on human nervous tissue are limited by neurosurgery and also by pathophysiological conditions prevailing before and after the resective operation. The electrophysiological study of receptors and channels becomes difficult also in animal models when the cells are not accessible and/or the experiments last many hours, during which the examined nervous tissue usually becomes unhealthy. To increase the possibility of doing optimal electrophysiological recordings, addressed to investigate the functional properties of receptors and channels, more than two decades ago, foreign mRNAs were injected into Xenopus oocytes to heterologously express the receptors; and about a decade ago cell membranes were injected into the oocytes to directly transplant the native receptors. While the first approach needs complex procedures for mRNA isolation, the membrane preparations are simpler to obtain and the embedded receptors are transplanted in their own membrane, with their own glycosylation and together with any ancillary proteins they may have. Using injections of membranes isolated from fresh nervous tissues several issues have already been addressed and many questions can be answered in the near future. Strikingly, with this approach it has been possible to "resuscitate" receptors and ion channels from tissues kept frozen for many years. This review focuses on recently obtained information and on some new lines of biological research using receptor microtransplantation into oocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428960     DOI: 10.1016/j.pneurobio.2009.01.008

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  17 in total

1.  Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.

Authors:  Eleonora Palma; Jorge Mauricio Reyes-Ruiz; Diego Lopergolo; Cristina Roseti; Cristina Bertollini; Gabriele Ruffolo; Pierangelo Cifelli; Emanuela Onesti; Cristina Limatola; Ricardo Miledi; Maurizio Inghilleri
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

2.  Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.

Authors:  Akihiko S Kato; Kevin D Burris; Kevin M Gardinier; Douglas L Gernert; Warren J Porter; Jon Reel; Chunjin Ding; Yuan Tu; Douglas A Schober; Matthew R Lee; Beverly A Heinz; Thomas E Fitch; Scott D Gleason; John T Catlow; Hong Yu; Stephen M Fitzjohn; Francesca Pasqui; He Wang; Yuewei Qian; Emanuele Sher; Ruud Zwart; Keith A Wafford; Kurt Rasmussen; Paul L Ornstein; John T R Isaac; Eric S Nisenbaum; David S Bredt; Jeffrey M Witkin
Journal:  Nat Med       Date:  2016-11-07       Impact factor: 53.440

3.  Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A.

Authors:  Romulo Araoz; Denis Servent; Jordi Molgó; Bogdan I Iorga; Carole Fruchart-Gaillard; Evelyne Benoit; Zhenhua Gu; Craig Stivala; Armen Zakarian
Journal:  J Am Chem Soc       Date:  2011-06-17       Impact factor: 15.419

4.  Physiological characterization of human muscle acetylcholine receptors from ALS patients.

Authors:  Eleonora Palma; Maurizio Inghilleri; Luca Conti; Cristina Deflorio; Vittorio Frasca; Alessia Manteca; Floriana Pichiorri; Cristina Roseti; Gregorio Torchia; Cristina Limatola; Francesca Grassi; Ricardo Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

Review 5.  Cyclic imine toxins from dinoflagellates: a growing family of potent antagonists of the nicotinic acetylcholine receptors.

Authors:  Jordi Molgó; Pascale Marchot; Rómulo Aráoz; Evelyne Benoit; Bogdan I Iorga; Armen Zakarian; Palmer Taylor; Yves Bourne; Denis Servent
Journal:  J Neurochem       Date:  2017-03-21       Impact factor: 5.372

6.  Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy.

Authors:  Manuela Mazzuferi; Eleonora Palma; Katiuscia Martinello; Francesca Maiolino; Cristina Roseti; Sergio Fucile; Paolo F Fabene; Federica Schio; Michele Pellitteri; Guenther Sperk; Ricardo Miledi; Fabrizio Eusebi; Michele Simonato
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

7.  Reconstitution of synaptic Ion channels from rodent and human brain in Xenopus oocytes: a biochemical and electrophysiological characterization.

Authors:  Francesca Mazzo; Ruud Zwart; Giulia Maia Serratto; Kevin M Gardinier; Warren Porter; Jon Reel; Giovanna Maraula; Emanuele Sher
Journal:  J Neurochem       Date:  2016-06-13       Impact factor: 5.372

8.  Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer's disease.

Authors:  Julie C Lauterborn; Pietro Scaduto; Conor D Cox; Anton Schulmann; Gary Lynch; Christine M Gall; C Dirk Keene; Agenor Limon
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

9.  The location of olfactory receptors within olfactory epithelium is independent of odorant volatility and solubility.

Authors:  Tatjana Abaffy; Anthony R Defazio
Journal:  BMC Res Notes       Date:  2011-05-06

10.  Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin.

Authors:  Alessandra Morano; Pierangelo Cifelli; Paolo Nencini; Letizia Antonilli; Jinane Fattouch; Gabriele Ruffolo; Cristina Roseti; Eleonora Aronica; Cristina Limatola; Carlo Di Bonaventura; Eleonora Palma; Anna Teresa Giallonardo
Journal:  Epilepsia Open       Date:  2016-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.